NHS-Galleri Trial

FDA Advisory Committee Supports Grail’s Test for Detecting Multiple Cancers

An independent expert committee voted that the potential benefits of Grail’s Galleri test outweigh its risks, paving the way for an FDA decision while emphasizing that it does not replace recommended cancer screenings.